Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
US-9,309,255 Process of a quaternary ammonium salt
The present invention relates to a novel process for preparing quaternary ammonium salt derivatives.
US-9,309,254 Pyrimidinyl-diazospiro compounds
The invention relates to spiro derivatives, to the use of said derivatives in treating diseases and conditions mediated by modulation of voltage-gated sodium...
US-9,309,253 Tricyclic pyrrolo derivatives, process for their preparation and their use as kinase inhibitors
The present invention relates to tricyclic pyrrolo derivatives which modulate the activity of protein kinases and are therefore useful in treating diseases...
US-9,309,252 Pyrrolopyrimidine compounds as inhibitors of CDK4/6
The invention is directed to novel pyrrolopyrimidine compounds of formula (1) wherein R.sup.1, R.sup.2y, R.sup.4, R.sup.8-R.sup.11, A and L are defined herein...
US-9,309,251 Bicyclic azaheterocyclobenzylamines as PI3K inhibitors
The present invention provides bicyclic azaheterocyclobenzylamines of Formula I: ##STR00001## wherein the variables are defined herein, that modulate the...
US-9,309,250 Substituted pyrrolo[2,3-b]pyrazines as ATR kinase inhibitors
The present invention relates to pyrrolopyrazines compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically...
US-9,309,249 Entecavir synthesis method and intermediate compound thereof
The present invention relates to a preparation method for a medicine and an intermediate compound thereof, specifically, relates to a preparation method for...
US-9,309,248 Azaindolines
Disclosed are compounds of Formula (I), or pharmaceutically acceptable salts thereof, wherein W, Y, Z, R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are as described in...
US-9,309,247 2-substituted imidazo[4,5-D]phenanthroline derivatives and their use in the treatment of cancer
The present invention provides 2-substituted imidazo[4,5-d]phenanthroline compounds, which are capable of inhibiting proliferation of one or more renal cancer...
US-9,309,246 Tricyclic heterocycles as BET protein inhibitors
The present invention relates to tricyclic heterocycles which are inhibitors of BET proteins such as BRD2, BRD3, BRD4, and BRD-t and are useful in the treatment...
US-9,309,245 Beta-lactamase inhibitor compounds
The present invention is directed to compounds which are beta-lacatamase inhibitors. The compounds and their pharmaceutically acceptable salts, are useful in...
US-9,309,244 Compound useful for the treatment of degenerative and inflammatory diseases
A novel compound able to inhibit JAK is disclosed, that comprises a compound according to Formula I: ##STR00001## or a pharmaceutically acceptable salt...
US-9,309,243 Imidazopyridine derivatives as modulators of TNF activity
A series of imidazo[1,2-a]pyridine derivatives of formula (I), being potent modulators of human TNFa activity, are accordingly of benefit in the treatment...
US-9,309,242 Substituted pyrido[2,3-b]pyrazines as FGFR kinase inhibitors
The invention relates to new pyridopyrazine derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of...
US-9,309,241 Naphthyridine derivative compounds
The invention relates to new naphthyridine derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of...
US-9,309,240 Pyrazolopyridine compounds, compositions and methods of use
The invention provides compounds of Formula I, stereoisomers or pharmaceutically acceptable salts thereof, wherein A, X, R.sup.1, R.sup.2, R.sup.4 and R.sup.5...
US-9,309,239 Substituted 6-fluoro-1H-pyrazolo[4,3-b]pyridines and use thereof
The present application relates to novel substituted 6-fluoro-1H-pyrazolo[4,3-b]pyridines, to processes for preparation thereof, to the use thereof, alone or in...
US-9,309,238 Imidazo [1,2-a]pyridine compounds, synthesis thereof, and methods of using same
Embodiments relate to the field of chemistry and biochemistry, and, more specifically, to imidazopyridine compounds, synthesis thereof, and methods of using...
US-9,309,237 HIV inhibitors
Chemical compounds that inhibit retroviruses are presented herein. More particularly, this disclosure provides small molecule compounds that inhibit infection...
US-9,309,236 PI-kinase inhibitors with broad spectrum anti-infective activity
Compounds and methods are provided for the treatment of pathogen infections. In some embodiments, the anti-infective compounds have broad spectrum activity...
US-9,309,235 SGC stimulators
Compounds of Formula I are described. They are useful as stimulators of sGC, particularly NO-independent, heme-dependent stimulators. These compounds may be...
US-9,309,234 Opioid receptor ligands and methods of using and making same
This application describes compounds that can act as opioid receptor ligands, which compounds can be used in the treatment of, for example, pain and pain...
US-9,309,233 Compositions and methods for the treatment of blood clotting disorders
The invention relates to the compounds of formula I and formula II or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers,...
US-9,309,232 Synthesis of novel inhibitors of isoprenoid biosynthesis
Antibacterial IspF inhibitor compounds and compositions are described. Methods include administering described compounds and compositions to treat bacterial or...
US-9,309,231 Bridged ring compounds as hepatitis C virus (HCV) inhibitors and pharmaceutical applications thereof
Provided herein is a compound having Formula (I), or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a...
US-9,309,230 Oligooxopiperazines and methods of making and using them
The present invention relates to oligooxopiperazines and their use. Methods for preparing oligooxopiperazines are also disclosed.
US-9,309,229 Crystalline forms of 5-chloro-N2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl)-N4-[2-(propan- ...
The present invention describes specific crystalline forms of 5-chloro-N-(2-isopropoxy-5-methyl-4-(piperidin-4-ylphenyl)-N-2-(isopropyl- ...
US-9,309,228 Fumaric acid salt of 9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy-quinazolin-6-yloxy]-1,4-di- ...
The present invention relates to a compound of formula (I), ##STR00001## which has valuable pharmacological properties, particularly an inhibiting effect on...
US-9,309,227 N-biphenylmethylbenzimidazole modulators of PPARG
The invention provides molecular entities that bind with high affinity to PPARG (PPAR.gamma.), inhibit cdk5-mediated phosphorylation of PPARG, but do not exert...
US-9,309,226 Crystalline form I of tyrosine kinase inhibitor dimaleate and preparation methods thereof
Provided are crystalline Form I of (R,E)-N-(4-(3-chloro-4-(pyridin-2-yl-methoxy)-phenylamino)-3-cyano-7-etho- xy-quinolin-6-yl)-3-(1-methylpyrrolidin-2-yl)...
US-9,309,225 N-((1-benzyl-1H-1,2,3-triazol-4-yl)methyl)arylamide compounds as potential anticancer agents and a process for...
The present invention provides a compound of general formula 1, useful as potential anticancer agents against human cancer cell lines and process for the...
US-9,309,224 N-acyl-N'-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities
Described are compounds of Formula 1 ##STR00001## which find utility in the treatment of cancer, autoimmune diseases and metabolic bone disorders through...
US-9,309,223 Heterocyclic compound, light-emitting element, light-emitting device, electronic device, and lighting device
Provided is a novel heterocyclic compound which can be used as a host material for dispersing a light-emitting material in a light-emitting layer of a...
US-9,309,222 Phenyl linked quinolinyl modulators of ROR.gamma.t
The present invention comprises compounds of Formula I. ##STR00001## wherein: R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8, and...
US-9,309,221 1-substituted indazole derivative
A medicament for treating diseases associated with cholinergic properties in the central nervous system (CNS) and/or peripheral nervous system (PNS), diseases...
US-9,309,220 Processes for the preparation of (S)-3-(4- ...
Provided are processes for the preparation of enantiomerically enriched or enantiomerically pure ...
US-9,309,219 Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
Provided are 4'-arylmethoxy isoindoline compounds, and pharmaceutically acceptable salts, solvates, clathrates, stereoisomers, and prodrugs thereof. Methods of...
US-9,309,218 2-Oxo-1,3-dioxolane-4-carboxamides, their preparation and use
The present invention suggests 2-oxo-1,3-dioxolane-4-carboxamides of formula (I), ##STR00001## in which R.sub.2 can be, inter alia, an n-valent radical...
US-9,309,217 Catalytic enantioselective synthesis of 2-aryl chromenes and related phosphoramidite ligands and catalyst compounds
Methods to access 2-aryl chromene compounds via an asymmetric catalytic process.
US-9,309,216 Process for preparation of optically pure and optionally substituted 2-(1-hydroxy-alkyl)-chromen-4-one...
The present invention relates to compounds useful as pharmaceutical intermediates, to processes for preparing the intermediates, to intermediates used in the...
US-9,309,215 Chiral intermediate, process for producing the same and its use in the manufacture of tolterodine,...
The compound of formula (I): is provided. It may be produced by subjecting a compound of formula (IV) to a reduction reaction wherein R represents hydrogen,...
US-9,309,214 Method for manufacturing neuraminic acid derivatives
A method for manufacturing a compound represented by the following formula (13): ##STR00001## wherein R.sup.2 represents a C.sub.1-C.sub.4 alkyl group and Ac...
US-9,309,213 C-3 substituted bicyclooctane based HIV protease inhibitors
C3-functionalized-cyclopentanyltetrahydrofuranyl carbamates that inhibit HIV proteolytic enzymes and processes for preparing the compounds are described....
US-9,309,212 Compositions and methods for modulating the activity of Epstein-Barr nuclear antigen 1
The present invention embraces compounds that modulate the activity of Epstein-Barr Nuclear Antigen 1 (BBNA1) protein and use thereof in methods for treating...
US-9,309,211 Arylalkene derivatives and use thereof as selective estrogen receptor modulators
The invention provides novel ethylene derivatives represented by Formula I, which may be used as selective estrogen receptor modulators (SERMs) and useful in...
US-9,309,210 Crystalline form of cabazitaxel and process for preparing the same
The present invention relates to a novel crystalline ethyl acetate solvate form of cabazitaxel or ...
US-9,309,209 Derivative of epichlorohydrin of natural origin
Derivative of epichlorohydrin of natural origin, selected from the group consisting of glycidyl ethers presenting an epoxide equivalent weight higher than or...
US-9,309,208 Methods of making and using thioxothiazolidine and rhodanine derivatives as HIV-1 and JSP-1 inhibitors
The present invention provides methods of making and using 5-(2-(indol-3-yl)-2-oxoethylidene)-3-phenyl-2-thioxothiazolidin-4-one derivatives having HIV-1 or...
US-9,309,207 Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa
The invention relates to compounds of the formula (I) which are inhibitors of activated thrombin-activable fibrinolysis inhibitor. The compounds of the formula...
US-9,309,206 Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4] oxadiazol-3-yl]-benzoic acid
The present invention relates to crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid, pharmaceutical compositions and dosage forms...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.